Actualités

From the probability of being born left-handed to Rare Diseases: The Mysteries of Tubulin Beta 4B Variations (TUBB4B)

Identification of a new key player in the immune control of Epstein-Barr virus infection

Discovery of a frequent genetic cause of autoimmunity From rare to frequent variants: the case of pre-TCRα deficiency

A new mutation implicated in autoimmune lymphoproliferative syndrome

CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration

Identification of a new genetic disease responsible for pulmonary alveolar proteinosis and mycobacterial infections

Autoantibodies against type I interferon : detected and active in childhood

A link established between brain plasticity and improved social skills in children with autism spectrum disorders

A new genetic disease linked to the X chromosome explains immunity problems in the face of mycobacteria

Criss-cross heart : how a shortage of cells affects the shape of the heart

Sanofi, WhiteLab Genomics, the TaRGeT Laboratory at Nantes University, and Institut Imagine launch WIDGeT to make France a global leader in gene therapy.

Autoantibodies against interferons, or why certain viruses affect us differently

Even our DNA can be recycled: the example of Cajal-Retzius cells

A new bifunctional gene therapy vector for sickle cell disease

MEDETIA, in partnership with Institut Imagine and Inserm Transfert, launches an innovative research program with Ipsen